To evaluate the effect of sLRIG3 on glioma microenvironment, patients of TCGA GBM cohort were divided into LRIG3-high group and LRIG3-low group based on the median value of LRIG3 sequencing value. This evidence concerns the gene LRIG3 and central nervous system cancer.